Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 265.00
Bid: 260.00
Ask: 270.00
Change: 0.00 (0.00%)
Spread: 10.00 (3.846%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 265.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Tungsten West 'largest Western tungsten producer'

Mon, 16th Jan 2023 16:26

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Aterian PLC - Morocco-focused metal exploration and development company - Identifies several new high-priority geophysical anomalies at its 100%-owned Agdz copper and silver project. Increases the target area due for further exploration. Chair Charles Bray says: "We are currently working towards building a conceptual geological model for the project, which has already demonstrated some excellent high-grade copper and silver values, up to 26.5% copper and 448 grams per tonne of silver. The presence of multiple historical copper workings at Agdz provides further encouragement, with the project located in an established copper and silver mining district in the eastern Anti-Atlas of Morocco and is an additional exciting exploration opportunity in our Moroccan portfolio."

----------

Quadrise Fuels International PLC - London-based energy solutions provider for a cleaner planet - Says bioMSAR fuel arrived at it client site in Morocco during December. The fuel is currently at Moroccan customs, awaiting final clearance. Expects the remaining logistical issues will be resolved this month so that the trial can then proceed as planned. Expects a successful trial to follow via discussions to conclude a commercial fuel supply agreement in the first half of 2023 as planned. Also announces commercial discussions for licence supply in Utah, US, progressing well, working towards execution of definitive agreements by the first quarter of 2023. Chief Executive Officer Jason Miles says: "Whilst we are frustrated with the delays that we have faced in progressing some of our projects, we remain confident that these will be overcome soon. The team has worked extremely diligently to seek to navigate these challenges such that the impact on the delivery of our projects should be minimal."

----------

Poolbeg Pharma PLC - London-based biopharmaceutical company focusing on infectious diseases - Files patent application to protect use of POLB 001 for new oncology indication. Says scientific finding indicate POLB 001 has the potential to dampen the pro-inflammatory cytokine release syndrome affecting patients receiving CAR T cell therapies. Submits a patent application for the use of POLB 001 to treat CRS in CAR T cell patients. Says it is progressing towards trial initiation in 2024. Scientific advisory board member Brendan Buckley says: "By reducing runaway inflammation associated with CRS, POLB 001 has the potential to significantly reduce the serious adverse effects that many CAR T cell patients suffer. With 18 to 19 million cases of cancer diagnosed globally each year, the use of cell therapies is predicted to expand significantly over the coming years with the CAR T cell market expected to grow to an estimated USD6 billion by 2031...we look forward to updating the market as to the progress of this exciting programme."

----------

Coro Energy PLC - Leeds, England-based energy company with a natural gas and clean energy portfolio - Says production from its Italian portfolio continued in line with expectations during the fourth quarter of 2022, following record quarterly revenues in the preceding quarter. Revenue is EUR1.5 million in the fourth quarter, down from EUR2.0 million in the third quarter, and marginally down from EUR1.6 million in the second quarter. Says 1.4 million standard cubic metres of natural gas were produced during the fourth quarter, up from 1.2 million in the third quarter, but down from 1.6 million in the second quarter. Full year 2022 natural gas production is 5.1 million standard cubic metres and revenue is EUR6.0 million. In the week ended January 8, Italian portfolio production averaged 21,091 standard cubic metres per day, up 50% from the 2022 annual average of 13,979 standard cubic metres per day.

----------

Upland Resources Ltd - Malaysia-focused upstream oil and gas company - Believes it is "unequally positioned" in Sarawak, Malaysia, providing the December workflow update on the SK334 joint technical study activity. Says time and resources spent in adding value to the Sarawak SK334 JTS workstream has the potential to generate "significant returns" to shareholders. Chair & Chief Executive Officer Bolhassan Di says: "Block SK334 in Sarawak offers transformational potential for a company our size, sedimentary basins in Sarawak are proven prolific hydrocarbons bearing basins. We are encouraged by the continuing recent discoveries in surrounding blocks...Separately, we also recognise the potential emerging from our UK North Sea P2478 Dunrobin prospect and are working closely with the joint venture partners to realise value there as technical studies complete."

----------

Bradda Head Lithium Ltd - North America-focused lithium development group - Says updated mineral resource estimate at its Basin East project in the US state of Arizona has increased by 17%, alongside a 22% increase in tonnes contained lithium carbonate equivalent, based on "only" 1,200 metres of drilling. Says the 2022 drilling programme has given the company "great confidence" in the estimate at Basin East. Chief Executive Officer Charles FitzRoy says: "2023 is going to be an exciting year of resource growth for Bradda Head. With more drilling already planned at Basin East Extension and Basin North, Bradda Head is excellently placed to take full advantage of the near-term resource growth potential at our sedimentary lithium assets in Arizona."

----------

Tungsten West PLC - Mining company focused on restarting production at the Hemerdon tungsten and tin mine in Devon, England - Says post-tax net present value is GBP297 million with an internal rate of return of 25%. Projects Hemerdon average annual production to be 2,900 tonnes of tungsten trioxide in concentrate and 310 tonnes of tin in concentrate. Says life of mine is 27 years with an an annual average steady-state mining rate of 3.5 megatonnes per annum. Says LOM post financing free cash flow is GBP550 million. Believes feasibility study shows company could be the largest Western tungsten producer. Says GBP12 million of capital expenditure already spent, with remaining capex being GBP31.1 million as of October 1. Executive Vice Chair Mark Thompson says: "The feasibility study provides solutions to the energy price challenges and will enable increased operating efficiencies at the project...Tungsten is on both the EU and US lists of critical metals and due to geopolitical tensions and security of supply issues the market remains strong. With Hemerdon in production, we will provide an alternative source of tungsten to Western consumers in markets which are otherwise dominated by China."

----------

ICG-Longbow Senior Secured UK Property Debt Investments Ltd - Guernsey-based investment company with a portfolio of UK real estate debt investments - Receives remaining GBP6.5 million balance of its LBS loan alongside GBP300,000 in interest and fees, following a refinancing of the underlying property. Says the repayment allows the company to continue its programme of capital distributions to shareholders.

----------

Faron Pharmaceuticals Ltd - Turku, Finland-based biopharmaceutical company focusing on difficult-to-treat cancers and inflammation via precision immunotherapy - Reports encouraging additional data for bexmarilimab for the treatment of hematological malignancies. Says it provoked objective responses in 3 out of 5 patients doesed in the first doublet cohort of the phase 1 and 2 Bexmab study. Says study showed rapid enrolment in doublet and triplet combinations. "The additional BEXMAB data indicates that bexmarilimab contributed to positive responses in the refractory setting where patients failed standard of care," says Chief Medical Officer Marie-Louise Fjallskog. "We are excited about the initial promising results and look forward to gathering additional clinical data for more robust read-outs."

----------

ACP Energy PLC - Lutterworth, England-based company looking for value-accretive opportunities in the oil and gas industry - Says shares are suspended as it signs a sale and purchase agreement for an equity interest being sold by Vinncler CA. Vinncler own the producing assets of a "highly prolific" basin in Latin America currently producing around 4,100 barrels per day, says ACP Energy. Says the proposed acquisition is in line with ACP Energy's stated strategy of identifying and acquiring hydrocarbon producing assets that are either in production or near to production. Says the proposed acquisition, if completed, will constitute a reverse takeover.

----------

By Greg Rosenvinge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
9 Jun 2023 14:34

TRADING UPDATES: Medica shareholders back takeover; Arecor optimistic

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Friday and not separately reported by Alliance News:

Read more
24 Apr 2023 14:21

Faron Pharmaceuticals test data shows efficacy of bexmarilimab

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said further data from its Phase I/II MATINS study of bexmarilimab has indicated the efficacy and safety of the immunotherapy in solid tumours.

Read more
17 Apr 2023 16:34

TRADING UPDATES: Anglo Asian gold output down; Faron hails antibody

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
29 Mar 2023 10:42

Faron Pharma names James O'Brien, once of Bristol-Myers, as new CFO

(Alliance News) - Faron Pharmaceuticals Ltd on Wednesday said it has appointed James O'Brien as its new chief financial officer, effective from Monday next week, succeeding Toni Hanninen.

Read more
29 Mar 2023 09:38

Faron Pharmaceuticals names James O'Brien as CFO

(Sharecast News) - Drug discovery and development company Faron Pharmaceuticals has tapped James O'Brien to take over as its new chief financial officer.

Read more
22 Mar 2023 17:12

Faron Pharmaceuticals gets positive feedback from FDA meeting

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals said on Wednesday that it had received positive feedback from the US Food and Drug Administration (FDA) on the development of its precision immunotherapy asset 'bexmarilimab'.

Read more
17 Mar 2023 15:42

UK shareholder meetings calendar - next 7 days

Monday 20 March 
Aukett Swanke Group PLCGM re proposed acquisition of Torpedo Factory Group Ltd
Pantheon Resources PLCAGM
Voyager Life PLCGM re subscription and fundraise
Tuesday 21 March 
BlackRock Sustainable American Income Trust PLCAGM
Gresham House Renewable Energy VCT 2 PLCAGM
React Group PLCAGM
Starvest PLCAGM
Sureserve Group PLCAGM
Wynnstay Group PLCAGM
Zamaz PLCGM re terms and conditions modification
Wednesday 22 March 
abrdn Private Equity Opportunities Trust PLCAGM
Asia Strategic Holdings LtdAGM
Circle Property PLCEGM re final disposal and cancellation
Genel Energy PLCAGM
Harmony Energy Income Trust PLCAGM
Titon Holdings PLCAGM
Thursday 23 March 
Crest Nicholson Holdings PLCAGM
Driver Group PLCAGM
Goldplat PLCAGM
Hardide PLCAGM
Idox PLCAGM
Zaim Credit Systems PLCGM re director removal and name change
Friday 24 March 
Faron Pharmaceuticals LtdAGM
In The Style Group PLCGM re sale of only subsidiary; becoming cash shell named Itsum PLC
Kitwave Group PLCAGM
Midatech Pharma PLCGM re cancellation of the admission to trading on AIM and name change
SME Credit Realisation Fund LtdEGM re cancellation of the company's listing
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
3 Mar 2023 11:53

Faron Pharmaceuticals annual loss widens on higher research costs

(Alliance News) - Faron Pharmaceuticals Ltd on Friday reported a widened loss in 2022 as it ramped up its research & development efforts.

Read more
24 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Monday 27 February 
Associated British Foods PLCTrading Statement
Beeks Financial Cloud Group PLCHalf Year Results
Bunzl PLCFull Year Results
Centralnic Group PLCFull Year Results
Dechra Pharmaceuticals PLCHalf Year Results
DX Group PLCHalf Year Results
GlobalData PLCFull Year Results
Greencoat Renewables PLCFull Year Results
Kosmos Energy LtdFull Year Results
Quartix Technologies PLCFull Year Results
RHI Magnesita NVFull Year Results
Senior PLCFull Year Results
Tuesday 28 February 
abrdn PLCFull Year Results
Benchmark Holdings PLCQ1 Results
Bluefield Solar Income Fund LtdHalf Year Results
boohoo Group PLCFull Year Results
Cap-XX LtdHalf Year Results
Croda International PLCFull Year Results
Dalata Hotel Group PLCFull Year Results
Derwent London PLCFull Year Results
Hutchmed (China) LtdFull Year Results
Intertek Group PLCFull Year Results
Kitwave Group PLCFull Year Results
Man Group PLCFull Year Results
McBride PLCHalf Year Results
Morgan Advanced Materials PLCFull Year Results
Ocado Group PLCFull Year Results
Princess Private Equity Holding LtdFull Year Results
Rotork PLCFull Year Results
Serco Group PLCFull Year Results
St James's Place PLCFull Year Results
S-Ventures PLCFull Year Results
Travis Perkins PLCFull Year Results
Uniphar PLCFull Year Results
Unite Group PLCFull Year Results
Videndum PLCFull Year Results
XP Power LtdFull Year Results
Wednesday 1 March 
Aston Martin Lagonda Global Holdings PLCFull Year Results
Capital & Counties Properties PLCFull Year Results
GetBusy PLCFull Year Results
Glenveagh Properties PLCFull Year Results
Global Invacom Group LtdFull Year Results
Haydale Graphene Industries PLCHalf Year Results
International Personal Finance PLCFull Year Results
Nichols PLCFull Year Results
Permanent TSB Group Holdings PLCFull Year Results
Persimmon PLCFull Year Results
Rathbones Group PLCFull Year Results
Reckitt Benckiser Group PLCFull Year Results
Ricardo PLCHalf Year Results
Weir Group PLCFull Year Results
Thursday 2 March 
Alfa Financial Software Holdings PLCFull Year Results
Apax Global Alpha LtdFull Year Results
Beazley PLCFull Year Results
Brooks Macdonald Group PLCHalf Year Results
Cairn Homes PLCFull Year Results
Capita PLCFull Year Results
Capital & Regional PLCFull Year Results
Coats Group PLCFull Year Results
CRH PLCFull Year Results
Flutter Entertainment PLCFull Year Results
Funding Circle Holdings PLCFull Year Results
Grafton Group PLCFull Year Results
Haleon PLCFull Year Results
Hunting PLCFull Year Results
ITV PLCFull Year Results
London Stock Exchange Group PLCFull Year Results
Melrose Industries PLCFull Year Results
Metro Bank PLCFull Year Results
National Express Group PLCFull Year Results
PPHE Hotel Group LtdFull Year Results
Schroder AsiaPacific Fund PLCFull Year Results
Schroders PLCFull Year Results
Spire Healthcare Group PLCFull Year Results
Taylor Wimpey PLCFull Year Results
Tritax Big Box REIT PLCFull Year Results
Tyman PLCFull Year Results
Vesuvius PLCFull Year Results
Friday 3 March 
Avation PLCHalf Year Results
Faron Pharmaceuticals LtdFull Year Results
IMI PLCFull Year Results
Pacific Horizon Investment Trust PLCHalf Year Results
Pearson PLCFull Year Results
Rightmove PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
27 Jan 2023 18:56

TRADING UPDATES: Diaceutics wins two deals; Faron proposes placing

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
27 Jan 2023 10:28

IN BRIEF: Faron Pharmaceuticals raises EUR12 million via shares

Faron Pharmaceuticals Ltd - Turku, Finland-based biopharmaceutical drug discovery and development company - Raises EUR12.0 million via placing of 3.7 million shares at the issue price of EUR3.25 each. Faron says that with these proceeds and the current level of activity, it has sufficient working capital into the third quarter of 2023.

Read more
27 Jan 2023 10:11

AIM WINNERS & LOSERS: Faron Pharmaceuticals raises EUR12 million

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
5 Dec 2022 12:06

Faron Pharmaceuticals sees patient remission in immunotherapy trials

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it was encouraged by promising early data from trials for its investigative precision immunotherapy, which aims to provide permanent immune stimulation for difficult-to-treat cancers by targeting myeloid cell function.

Read more
1 Dec 2022 21:42

TRADING UPDATES: Renalytix hails trial results; Kingswood buys JFP

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.